1,417 results
Search Results
2. Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers
3. Rifampicin in plasma and pleural fluid after single oral doses
4. Pharmacokinetics — Uses and abuses
5. Influence of the cytochrome P4502D6*4 allele on the pharmacokinetics of controlled-release metoprolol
6. Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics
7. Letters to the editors Nonlinear kinetics of nortriptyline in every day practice*
8. Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma
9. Pharmacokinetics of mestranol in man in relation to its oestrogenic activity
10. Comparative pharmacokinetic analysis of amoxycillin using open two and three-compartment models
11. Tolerability and pharmacokinetics of L-648,051. A leukotriene D4-receptor antagonist, in healthy volunteers
12. Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy
13. Disposition of dibekacin in patients undergoing haemodialysis
14. Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses
15. Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency
16. Evaluation of a micromethod for determination of antibiotic concentrations in plasma
17. Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers
18. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection
19. Pharmacokinetics of teduglutide in subjects with renal impairment
20. Therapeutic drug monitoring for tomorrow
21. Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers
22. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects
23. CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects
24. Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers
25. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
26. Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation
27. Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers
28. Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis
29. Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR)
30. Medication prescribing in frail older people
31. The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent
32. Pharmacokinetic and pharmacodynamic effects of comedication of clopidogrel and dabigatran etexilate in healthy male volunteers
33. Pharmacokinetics of transdermal buprenorphine patch in the elderly
34. Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects
35. Relative bioavailability and pharmacodynamic effects of methantheline compared with atropine in healthy subjects
36. Pharmacokinetics of the novel PAR-1 antagonist vorapaxar in patients with hepatic impairment
37. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients
38. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension
39. Absorption of different oral dosage forms of oxycodone in the elderly: a cross-over clinical trial in patients undergoing cystoscopy
40. Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients
41. Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery
42. Entry-into-humans study with a new direct renin inhibitor
43. CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers
44. Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals
45. Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain
46. Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease
47. Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis
48. Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects
49. Repeat-dose sirolimus pharmacokinetics and pharmacodynamics in patients with hepatic allografts
50. Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.